[Observation on effect of shenmai injection in treating patients of congestive heart failure].
To observe the clinical therapeutic effect of Shenmai Injection (SMI) in treating patients of congestive heart failure. Effect of 16 cases treated with SMI or potassium magnesium aspartate was observed by randomized crossover method and compared. By using SMI for 2 weeks, patients' left ventricular ejective fraction (LVEF) could be increased from 29.5 +/- 9.0 to 36.6 +/- 10.2 (P < 0.05), the heart function of 68.75% patients was improved, no side effects or toxicity was observed. Potassium magnesium asparate could improve heart function in 37.50% patients only but with no effect on LVEF. SMI is an effective and safe therapy in treating patients with congestive heart failure.